Pediatric

Dr. Oved completed scientific and clinical training that included tenures as a Fulbright Fellow with the Weizmann Institute in Israel, the NYU School of Medicine with two years as a Howard Hughes Medical Fellow, followed by a residency in Pediatrics at NYP Weill Cornell Medical College. During his residency, he developed an interest in more translational questions working with Dr. James Bussel to test a novel combination of dexamethasone and rituximab for pediatric patients with chronic idiopathic thrombocytopenic purpura (ITP).

Dr. Michael Burke is an Associate Professor at the Children’s Hospital of Wisconsin (CHW) in the Division of Hematology/Oncology/Blood & Marrow Transplantation. He is Director of the Pediatric Leukemia & Lymphoma Program at CHW and Co-Director of the Developmental Therapeutics Program where he oversees all early phase clinical trials (Phase I and II studies) at CHW. He has developed both early phase and upfront clinical trials in acute leukemia that have opened locally here at CHW as well as nationally and internationally through consortiums such as the Children’s Oncology Group (COG) and the

Angela Smith joined the Department of Pediatrics in July 2008 in the Division of Hematology/Oncology/Blood and Marrow Transplantation and became Director of the Division Blood and Marrow Transplantation in 2019. Dr. Smith graduated with her medical degree from the Medical College of Wisconsin in 2002. She then went on to complete her internship and residency in Pediatrics at the University of Minnesota. Following residency, she completed a fellowship in Pediatric Hematology/Oncology/Blood and Marrow Transplantation at the University of Minnesota in June 2008. During her fellowship, she also